Open access · CC-BY
via OpenAlex
Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments
Zhengdong Zhang, Pan Liu, Yu Song, Liang Ma, Yan Xu, Jie Lei, Bide Tong, Dingchao Zhu, Huaizhen Liang, Hongchuan Wang, Xingyu Zhou, Zixuan Ou, Junyu Wei, Hanpeng Xu, Di Wu
Clinical and Translational Medicine · 2025 · ▲ 20 citations
Genomic instability
Telomere attrition
Cellular senescence
Altered intercellular communication
Human
Review
Abstract
BACKGROUND: Osteoblast senescence(definition) is a central driverof age-related osteoporosis. Accumulating evidence shows that counteractingthis senescence can substantially mitigate bone loss. In this review, we summarize the hallmarks of osteoblast senescence, the signaling pathways involved, and therapeutic strategies that target osteoblast senescence tocombat age-related osteoporosis. METHODS: Chronic diseases associated with ageingpose a significant threat to human health. Studies have shown that osteoporosisis closely linked to the ageing process of the body and the senescence ofosteoblasts within the bone microenvironment. Counteracting the senescence ofosteoblasts and maintaining the balance of differentiation, proliferation andfunction between osteoclasts and osteoblasts has been a key focus in the research of age-related osteoporosis and bone loss. The biological behaviour andfunctionality of the osteoblast lineage related to senescence are modulated bya variety of targets, including signalling pathways, proteins and genes associated with ageing. This review aims to discuss the senescence-related characteristics of the osteoblast lineage, dissect the interplay and mechanisms between it and ageing-associated signalling pathways, proteinsand genes, as well as current strategies for the prevention and treatment ofosteoblast senescence. CONCLUSION: This review systematically examines the regulatory interactions among markers, therapeutic targets, and signalingpathways associated with osteoblast senescence, alongside current potential strategies for targeting this process. It provides more comprehensive information for future research into the complex mechanisms underlying age-related osteoporosis driven by osteoblast senescence. KEY POINTS: Osteoblast senescence is a key driver of age-related osteoporosis, disrupting bone formation and homeostasis. Aging impacts osteoblasts through multiple pathways, including telomere(definition) shortening, genomic instability, SASP secretion, and others. Bone loss related to osteoblast senescence involves the activation and crosstalk of multiple signaling pathways. The options for combating and treating osteoblast senescence toachieve anti-osteoporosis are numerous, but still challenging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/ctm2.70417
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Zhang, Z., Liu, P., Song, Y., Ma, L., Xu, Y., Lei, J., Tong, B., Zhu, D., Liang, H., Wang, H., Zhou, X., Ou, Z., Wei, J., Xu, H., Wu, D., Peng, S., Du, Y., Du, Z., Wang, B., & Liao, Z. (2025). Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments. <em>Clinical and Translational Medicine</em>. https://doi.org/10.1002/ctm2.70417
Vancouver
Zhang Z, Liu P, Song Y, Ma L, Xu Y, Lei J, et al. Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70417.
BibTeX
@article{zhengdong2025Addres,
title = {Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments},
author = {Zhengdong Zhang and Pan Liu and Yu Song and Liang Ma and Yan Xu and Jie Lei and Bide Tong and Dingchao Zhu and Huaizhen Liang and Hongchuan Wang and Xingyu Zhou and Zixuan Ou and Junyu Wei and Hanpeng Xu and Di Wu and Shuchang Peng and Yifan Du and Zhi Du and Bingjin Wang and Zhiwei Liao and Wencan Ke and Kangcheng Zhao and Xiqin Xia and Lei Tan and Xiaobo Feng},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70417},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cellular & Molecular Biology Letters 2023
Open access · CC-BY
Cellular senescence in skeletal disease: mechanisms and treatment
Cellular and Molecular Life Sciences 2022
Open access · CC-BY
ROS-induced PADI2 downregulation accelerates cellular senescence via the stimulation of SASP production and NFκB activation
International Journal of Molecular Sciences 2021
Open access · CC-BY
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics
Cell Proliferation 2022
Open access · CC-BY
Senescent cells: A therapeutic target for osteoporosis
Frontiers in Endocrinology 2026
Open access · CC-BY
The role and mechanisms of bone microenvironment regulators in osteoporosis: novel intervention strategies for addressing the challenges of aging
Endocrinology and Metabolism Clinics of North America 2005
Citation only